Skip to main content
Log in

Combined postoperative treatment of malignant supratentorial gliomas with vincristine sulphate and radiotherapy

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The results of combined irradiation and intravenous Vincristine therapy applied to 18 malignant glioma patients after operation and reoperation are reported. Histological examination of the first 15 tumours showed that 12 were glioblastomas and 3 malignant astrocytomas. Tumours removed by reoperation were glioblastomas.

Combination therapy consisted of the immediate postoperative administration of 6–12 mg VCR (0.08–0.1 mg/kg) over an 8–14 days period followed by 2 courses of telecobalt irradiation giving a total dose of 5,000 rads. Most patients received a second course of 8–12 mg VCR 6 months after surgery. The total dose of VCR was 15–22 mg. Irreversible toxic effects were not observed.

The results obtained with combination therapy were somewhat better than those achieved with radiotherapy alone. The mean survival time was 9 months. Patients lived after re-operation for at least as long as they had after a first operation. Death did not occur within a period of 6 months following surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Áfra, D., Vincristine therapy in malignant glioma recurrences. Neurochirurgia, in press.

  2. Bering, Jr. E. A., C. B. Wilson, and H. A. Norrel, The Kentucky Conference on Brain Tumor Chemotherapy. J. Neurosurg.27 (1967), 1–10.

    PubMed  Google Scholar 

  3. Boldrey, E. B., Surgical procedures for malignant brain tumors. Ann. N.Y. Acad. Sci.159 (1969), 558–566.

    Google Scholar 

  4. Braham, J., I. Sarova-Pinhas, and Y. Goldhammer, Glioma of the brain treated by intravenous Vincristine sulphate. Neurochirurgia (Stuttgart)12 (1969), 195–200.

    Google Scholar 

  5. Broder, L. E., and D. P. Ball, Chemotherapy of brain tumors. Progr. exp. Tumor Res.17 (1972), 373–399.

    PubMed  Google Scholar 

  6. Dean, M. R. E., A. Newton, and G. F. Swann, Percutaneous intraarterial chemotherapy in the treatment of intracranial neoplasms: a review of 36 cases. Brit. J. Radiol.40 (1967), 828–833.

    PubMed  Google Scholar 

  7. Fränkel, S. A., and W. J. German, Glioblastoma multiforme. A review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment. J. Neurosurg.15 (1958), 489–503.

    PubMed  Google Scholar 

  8. Greenhouse, A. H., Neuberger, and D. L. Bowerman, Brain damage after intracarotid infusion of methotrexate. Arch. Neurol. (Chicago)11 (1964), 618–625.

    Google Scholar 

  9. Jelsma, R., and P. C. Bucy, The treatment of glioblastoma multiforme of the brain. J. Neurosurg.27 (1967), 388–400.

    PubMed  Google Scholar 

  10. Lassman, L. P., G. W. Pearce, M. Banna, and R. D. Jones, Vincristine sulphat in the treatment of skeletal metastases from cerebellar medulloblastoma. J. Neurosurg.30 (1969), 42–49.

    PubMed  Google Scholar 

  11. Magdon, E., A. Szekulesz, H. Baudach, K. Hübner, G. Baust und P. Schaps, Untersuchungen zur regionalen Tumortherapie des Gehirns. Dtsch. Gesundheitswesen20 (1965), 1929–1935.

    Google Scholar 

  12. Mealey, Jr. J., Treatment of malignant cerebral astrocytomas by intracranial infusion of Vinblastine. Cancer Chemother. Rep.20 (1962), 121–126.

    PubMed  Google Scholar 

  13. Neuss, N., S. Johnson, J. G. Armstrong, and C. J. Jansen, The Vinca Alkaloids. Advances in Chemother.1 (1964), 133–174.

    Google Scholar 

  14. Owens, G., Chemotherapy of brain tumors. Progr. neurol. Surg.1 (1966), 190–201. Basel-New York: Karger.

    Google Scholar 

  15. —, Intraarterial chemotherapy of primary brain tumors. Ann. N.Y. Acad. Sci.159 (1969), 603–607.

    Google Scholar 

  16. Pool, J. R., and R. P. Kamrin, The treatment of intracranial gliomas by surgery and radiation. Progr. neurol. Surg.1 (1966), 258–299.

    Google Scholar 

  17. Sellei, C., S. Eckhardt, and L. Németh, Chemotherapy of Neoplastic Diseases. Budapest: Akadémiai Kiadó. 1970.

    Google Scholar 

  18. Simon, G., Chemotherapie der malignen Hirngeschwülste. In: Handbuch der Neurochirurgie IV/4, S. 567. Berlin-Heidelberg-New York: Springer. 1967.

    Google Scholar 

  19. Taveras, J. M., H. G. Thompson, and J. L. Pool, Should we treat glioblastoma multiforme? Amer. J. Roentgenol.87 (1962), 473–479.

    PubMed  Google Scholar 

  20. Uihlein, A., M. Y. Colby, D. D. Layton, W. R. Parsons, and T. L. Carter, Comparison of surgery and surgery plus irradiation in the treatment of supratentorial gliomas. Acta Radiol. (Ther.)5 (1966), 67–78.

    Google Scholar 

  21. Wilson, C. B., Chemotherapy of brain tumors by continous arterial infusion. Surgery55 (1964), 640–653.

    PubMed  Google Scholar 

  22. Wilson, C. B., and T. Hoshino, Current trends in the chemotherapy of brain tumors with special reference to glioblastomas. J. Neurosurg.31 (1969), 589–603.

    PubMed  Google Scholar 

  23. Zoltán, L., D. Áfra, and G. Benoist, Further improvements in the therapy of the supratentorial semimalignant astrocytomas and glioblastomas (chemotherapy and reoperation). Present limits of neurosurgery. Proceedings of the fourth European Congress of Neurosurgery. Prague Avicenum (1972), 105–108.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Áfra, D., Zoltán, L., Gyenes, G. et al. Combined postoperative treatment of malignant supratentorial gliomas with vincristine sulphate and radiotherapy. Acta neurochir 29, 203–211 (1973). https://doi.org/10.1007/BF01406171

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01406171

Keywords

Navigation